These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2155831)

  • 1. Complete purification of two identical Na(+)-pump inhibitors isolated from bovine hypothalamus and hypophysis.
    Illescas M; Ricote M; Mendez E; G-Robles R; Sancho J
    FEBS Lett; 1990 Feb; 261(2):436-40. PubMed ID: 2155831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium transport inhibitor from bovine hypothalamus.
    Haupert GT; Sancho JM
    Proc Natl Acad Sci U S A; 1979 Sep; 76(9):4658-60. PubMed ID: 228304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial purification and properties of the inhibitors of Na, K-ATPase and ouabain-binding in bovine central nervous system.
    Akagawa K; Hara N; Tsukada Y
    J Neurochem; 1984 Mar; 42(3):775-80. PubMed ID: 6319608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of the purified hypothalamic pituitary NA/K-ATPase inhibitor.
    Sancho JM; Garcia-Martin E; Garcia-Robles R; Santirso R; Villa E; Gutierrez-Merino C; Ricote M
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S32-4. PubMed ID: 7508022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
    Tamura M; Harris TM; Konishi F; Inagami T
    Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A non-ouabain Na/K ATPase inhibitor isolated from bovine hypothalamus. Its relation to hypothalamic ouabain.
    Sancho JM
    Clin Exp Hypertens; 1998; 20(5-6):535-42. PubMed ID: 9682909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic sodium-transport inhibitor is a high-affinity reversible inhibitor of Na+-K+-ATPase.
    Haupert GT; Carilli CT; Cantley LC
    Am J Physiol; 1984 Dec; 247(6 Pt 2):F919-24. PubMed ID: 6095682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial purification of a sodium pump inhibitor from bovine adenohypophysis. Its comparison with the natriuretic factor isolated from hypothalamus.
    Illescas M; Ricote M; Méndez E; Robles RG; Sancho JM
    Clin Exp Hypertens A; 1988; 10 Suppl 1():301-7. PubMed ID: 2854013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic Na(+)-K(+)-ATPase inhibitor characterized in two-sided liposomes containing pure renal Na(+)-K(+)-ATPase.
    Anner BM; Rey HG; Moosmayer M; Meszoely I; Haupert GT
    Am J Physiol; 1990 Jan; 258(1 Pt 2):F144-53. PubMed ID: 2154124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ouabain and hypothalamic, hypophysary inhibitory factor on rat mesangial cell proliferation.
    Montero A; Rodriguez-Barbero A; Ricote M; Sancho J; Lopez-Novoa JM
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S35-7. PubMed ID: 7508023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive inotropic effects of the endogenous Na+/K(+)-transporting ATPase inhibitor from the hypothalamus.
    Hallaq HA; Haupert GT
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10080-4. PubMed ID: 2557617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Na,K-ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: nanogram scale CD structural analysis.
    Zhao N; Lo LC; Berova N; Nakanishi K; Tymiak AA; Ludens JH; Haupert GT
    Biochemistry; 1995 Aug; 34(31):9893-6. PubMed ID: 7632688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ouabainlike factor in Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of palmitylcarnitine on ouabain binding to Na, K-ATPase.
    Adams RJ; Pitts BJ; Woods JM; Gende OA; Wallick ET; Schwartz A
    J Mol Cell Cardiol; 1979 Oct; 11(10):941-59. PubMed ID: 230355
    [No Abstract]   [Full Text] [Related]  

  • 15. Na+ pump in renal tubular cells is regulated by endogenous Na+-K+-ATPase inhibitor from hypothalamus.
    Cantiello HF; Chen E; Ray S; Haupert GT
    Am J Physiol; 1988 Oct; 255(4 Pt 2):F574-80. PubMed ID: 2845805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific endogenous Na, K-ATPase inhibitor purified from bovine adrenal.
    Tamura M; Lam TT; Inagami T
    Biochem Biophys Res Commun; 1987 Dec; 149(2):468-74. PubMed ID: 2827643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous "ouabain-like" activity in bovine plasma.
    Tal DM; Katchalsky S; Lichtstein D; Karlish SJ
    Biochem Biophys Res Commun; 1986 Feb; 135(1):1-8. PubMed ID: 3006675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The search for a hypothalamic Na+,K+-ATPase inhibitor.
    Haber E; Haupert GT
    Hypertension; 1987 Apr; 9(4):315-24. PubMed ID: 2435655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal.
    Tamura M; Lam TT; Inagami T
    Biochemistry; 1988 Jun; 27(12):4244-53. PubMed ID: 2844224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between catecholamine secretion from bovine isolated chromaffin cells and [3H]-ouabain binding to plasma membranes.
    Aunis D; García AG
    Br J Pharmacol; 1981 Jan; 72(1):31-40. PubMed ID: 6164427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.